SHANGHAI HI SILICON TECHNOLOGY CO., LTD.
SHANGHAI HI SILICON TECHNOLOGY CO., LTD.

Sophorolipid: Major Process Improvements & Breakthroughs of Well-Known Brands with High Market Share in China and Globally

Table of Content [Hide]

    As a new foreign trade service provider driven by both technology transformation and foreign trade services, HiSiaddi has established a "1+2+3+4=1" service system and can supply raw materials of Sophorolipid from multiple well-known original manufacturers.

    As a R&D-oriented foreign trade enterprise, HiSiaddi does not only promote its own brand like single-brand factories. We objectively analyze multiple well-known brands with high market share in China and globally and share their major technological processes and breakthroughs, enabling purchasers to access authentic, effective and up-to-date market information.

    If you require more comprehensive and valuable market information on Sophorolipid, please contact HiSiaddi customer service.

    I. Core Breakthroughs of China’s Top 5 Export Sophorolipid Brands (Shandong Baisheng, Zhejiang Xinyinxiang, Jiangsu Huike, Shaanxi Deguan, Nanjing Sibike)

    (I) Mass Production Breakthrough via Gene-Edited Strains

    Significantly improved fermentation yield directly reduces raw material procurement costs. Breakthrough highlights: All five top manufacturers have fully implemented CRISPR whole-genome editing to modify Candida strains, replacing traditional mutagenesis breeding technologies. Shandong Baisheng achieved a glucose substrate yield of 48.6g/L (51.4% higher than the industry average of 32.1g/L); Shaanxi Deguan optimized strains to reach a final fermentation concentration of 280g/L, a 124% increase over traditional processes. Downstream benefits: Unit raw material production costs decreased by 27%~35%, and our export quotations dropped by 18% on average compared with 2023. Purchasers cut per-ton raw material stocking costs, and downstream daily chemical and pesticide formulations reduced raw material addition costs by over 12%.

    (II) Enzymatic Refining Process Breakthrough

    Upgraded selectivity of high-purity products realizes domestic substitution of medical and electronic-grade products. Breakthrough highlights: Shandong Runde (supporting production capacity for Top 5 brands) and Jiangsu Huike built thousand-ton enzymatic deacetylation refining production lines, raising selectivity of acidic sophorolipids from 76.2% under traditional acid hydrolysis to 93.5%. Jiangsu Huike’s medical-grade sophorolipid completed US FDA DMF filing (DMF42897) with stable purity ≥98.5%, breaking monopolies of high-purity products from Japan and South Korea. Downstream benefits: Purchasers no longer need to import high-purity sophorolipids from Europe and America at premium prices, with procurement unit prices of raw materials for medical dressings, vaccine adjuvants and electronic wafer cleaners reduced by 32%. Downstream manufacturers eliminate secondary purification procedures, shortening production cycles by 15%.

    (III) Intelligent Continuous Fermentation Breakthrough

    Domestically automated production lines cut energy consumption and emissions, with batch stability meeting EU long-term certification standards. Breakthrough highlights: Zhejiang Xinyinxiang independently developed domestic intelligent fermentation control systems; all Top 5 manufacturers replaced batch production with continuous fermentation, cutting comprehensive energy consumption per ton of product by 32% and reducing wastewater COD from 18600mg/L to 4200mg/L. Nanjing Sibike’s modular flexible production lines realize rapid formula change within 48 hours, delivering customized small-batch global orders within 7 days. Downstream benefits: Batch-to-batch fluctuation of lactone/acid ratios ≤±2%, satisfying EU long-term stability audits for cosmetics. Delivery cycles for purchasers’ small-batch multi-specimen trial orders are shortened from 30 days to 7–10 days, lowering inventory stocking pressure.

    (IV) Derivative Molecular Modification Breakthrough

    Industrialized production of acetylated sophorolipids opens new segments for medical adjuvants and wound dressings. Breakthrough highlights: Shandong Baisheng completed pre-clinical trials of acetylated modified sophorolipids as mRNA vaccine adjuvants. Shanghai Weigou Workshop (R&D partner of Top 5 brands) obtained domestic innovative medical device approval for sophorolipid-chitosan nanocomposites, launching mass production of the world’s first sophorolipid-based medical wound dressing raw material. Downstream benefits: Purchasers gain access to new subdivided categories of medical dressings and biological vaccine raw materials. Downstream medical device manufacturers can replace traditional chemical bacteriostatic raw materials; finished products pass EU low-irritation medical raw material certification and enjoy higher premium margins.

    II. Technological Breakthroughs of Global Top 5 Overseas Sophorolipid Brands (Evonik, BASF, Saraya (Japan), Jeneil (USA), Soliance (France))

    (I) Breakthrough in Fermentation Using Renewable Waste Raw Materials

    Agricultural and forestry waste replaces refined oil to slash raw material costs for overseas manufacturers. Breakthrough highlights: Evonik and BASF launched dual-carbon-source fermentation routes using kitchen waste oil and corn stalk hydrolyzed sugar, cutting raw material costs by 21% compared with palm oil-based substrates. Jeneil’s agricultural waste resource utilization fermentation technology achieves a raw material utilization rate of 92%, decoupling production from palm oil price cycles. Downstream benefits: Benchmark supply prices of overseas original manufacturers keep declining, enabling domestic purchasers to flexibly switch between domestic and imported raw materials to hedge price hikes. Carbon footprints of downstream cleaning products drop by 40%, complying with EU Carbon Border Adjustment Mechanism requirements.

    (II) Breakthrough in pH-Responsive Emulsification Modification

    Customized sophorolipid emulsification systems simplify and upgrade cosmetic formulations. Breakthrough highlights: Soliance (France) developed pH-targeted modified sophorolipids with 98% room-temperature emulsion stability, compatible with full-range weak acid to weak alkali skincare formulations. Saraya (Japan) nano-encapsulated modified sophorolipids for pesticide adjuvants extend field efficacy duration from 18 days to 42 days. Downstream benefits: Daily chemical purchasers reduce 3~5 auxiliary emulsifying additives in formulations, cutting terminal skincare product formulation costs by 8%. Pesticide manufacturers reduce terminal pesticide application dosage by 25%, lowering farmers’ end-use costs.

    (III) Breakthrough in Food-Grade Compliant Modification

    Dual certifications of EU Novel Food and US GRAS remove access barriers for food emulsification and defoaming applications. Breakthrough highlights: CJ (South Korea, supporting capacity for global Top 5 brands) and Saraya obtained dual regulatory certifications for food-grade sophorolipids, eliminating market access barriers for food emulsification and defoaming. BASF’s low-residue modified products contain no 1,4-dioxane by-products, meeting global maternal and infant food raw material standards. Downstream benefits: Food purchasers fully implement domestic substitution in baking and beverage defoaming applications. End food brands may label fully natural bio-based raw materials to boost product market competitiveness.

    (IV) Breakthrough in High Salt Tolerance Modification for Oilfield Applications

    Upgraded compatibility with high-mineralization formations enhances oil recovery rate in tertiary oil recovery. Breakthrough highlights: Locus (Evonik partner) developed high salt-tolerant modified sophorolipids resistant to formation mineralization up to 120,000 ppm, far exceeding the 50,000 ppm tolerance limit of conventional products. A 0.05% dosage achieves 69.57% crude oil stripping efficiency from oily sludge, outperforming traditional petrochemical surfactants. Downstream benefits: Oilfield chemical purchasers utilize a single raw material for both oil displacement and oily sludge treatment, boosting terminal oilfield recovery rates by 7~9 percentage points and lowering comprehensive extraction costs.

    III. General Procurement Benefits Brought by Universal Technological Breakthroughs of All Product Categories

    1. Performance benefit: Critical micelle concentration (CMC) of new products from all leading brands decreased by 40% year-on-year, cutting raw material addition dosage of terminal products by 30% and drastically reducing per-ton finished product raw material consumption for purchasers.

    2. Compliance benefit: Biodegradation rate of all leading products ≥99.2%, meeting EU Green New Deal 2030 bio-surfactant quota requirements and enabling purchasers to avoid environmental tariffs for EU-bound end products.

    3. Supply chain benefit: Successive commissioning of ten-thousand-ton domestic production bases raises global spot supply of sophorolipids by 38%, strengthening purchasers’ bargaining power for long-term fixed-price agreements and avoiding price surges caused by raw material shortages.

    If you require more comprehensive and valuable market information on Sophorolipid, please contact HiSiaddi customer service.


    References
    We use cookies to optimise and personalise your experience, but you can choose to opt out of non-essential cookies.
    To find out more, read our Privacy Policy
    Reject All
    Accept All